117 related articles for article (PubMed ID: 1647340)
1. The mode of vasorelaxing action of melatonin in rabbit aorta.
Satake N; Oe H; Sawada T; Shibata S
Gen Pharmacol; 1991; 22(2):219-21. PubMed ID: 1647340
[TBL] [Abstract][Full Text] [Related]
2. Vasorelaxing action of melatonin in rat isolated aorta; possible endothelium dependent relaxation.
Satake N; Oe H; Shibata S
Gen Pharmacol; 1991; 22(6):1127-33. PubMed ID: 1667303
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of the vasorelaxing action of (3E)-4-ethyl-2-hydroximino-5-nitro-3-hexamide FK409, a new vasodilator isolated from microbial sources, in isolated rabbit arteries.
Shibata S; Satake N; Sato N; Matsuo M; Koibuchi Y; Hester RK
J Cardiovasc Pharmacol; 1991 Mar; 17(3):508-18. PubMed ID: 1711615
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
[TBL] [Abstract][Full Text] [Related]
5. Reversal or nitroglycerin tolerance by the cGMP phosphodiesterase inhibitor zaprinast.
Silver PJ; Pagani ED; de Garavilla L; Van Aller GS; Volberg ML; Pratt PF; Buchholz RA
Eur J Pharmacol; 1991 Jun; 199(1):141-2. PubMed ID: 1654265
[No Abstract] [Full Text] [Related]
6. Vasorelaxing action of melatonin in rabbit basilar artery.
Shibata S; Satake N; Takagi T; Usui H
Gen Pharmacol; 1989; 20(5):677-80. PubMed ID: 2606335
[TBL] [Abstract][Full Text] [Related]
7. Vasoinhibitory action of KT2-734, an antihypertensive agent, in isolated rat aorta.
Satake N; Zhou Q; Kosakai K; Nimura M; Shibata S
Eur J Pharmacol; 1994 Jan; 251(1):1-7. PubMed ID: 8137865
[TBL] [Abstract][Full Text] [Related]
8. Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine.
Souness JE; Brazdil R; Diocee BK; Jordan R
Br J Pharmacol; 1989 Nov; 98(3):725-34. PubMed ID: 2480168
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor.
Merkel LA; Rivera LM; Perrone MH; Lappe RW
Eur J Pharmacol; 1992 May; 216(1):29-35. PubMed ID: 1326438
[TBL] [Abstract][Full Text] [Related]
10. Relaxing effect of nicorandil (N-2-(hydroxyethyl)-nicotinamide nitrate), a new anti-angina agent, on the isolated vascular smooth muscle.
Shibata S; Satake N; Takagi T; Kerfoot F; Suh TK
Eur J Pharmacol; 1984 Mar; 99(2-3):219-26. PubMed ID: 6234181
[TBL] [Abstract][Full Text] [Related]
11. Contribution of activation of K+ channels to glyceryl trinitrate-induced relaxation of rabbit aorta.
Ishibashi T; Kawada T; Kato K; Hamaguchi M; Imai S
Gen Pharmacol; 1995 May; 26(3):543-52. PubMed ID: 7540579
[TBL] [Abstract][Full Text] [Related]
12. Mode of relaxing action of FK336, a new antianginal agent, in rabbit aorta.
Satake N; Kiyoto S; Zhou Q; Matsuo M; Shibata S
Gen Pharmacol; 1992 May; 23(3):409-16. PubMed ID: 1355057
[TBL] [Abstract][Full Text] [Related]
13. Isoenzymes of cyclic nucleotide phosphodiesterase in the human aorta: characterization and the effects of E4021.
Miyahara M; Ito M; Itoh H; Shiraishi T; Isaka N; Konishi T; Nakano T
Eur J Pharmacol; 1995 Sep; 284(1-2):25-33. PubMed ID: 8549633
[TBL] [Abstract][Full Text] [Related]
14. The potentiation of nitroglycerin-induced relaxation by PKG inhibition in rat aortic rings.
Satake N; Fujimoto S; Shibata S
Gen Pharmacol; 1996 Jun; 27(4):701-5. PubMed ID: 8853308
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of the novel vasodilator FK409 with those of nitroglycerin in isolated coronary artery of the dog.
Yamada H; Yoneyama F; Satoh K; Taira N
Br J Pharmacol; 1991 Jul; 103(3):1713-8. PubMed ID: 1681975
[TBL] [Abstract][Full Text] [Related]
16. Relationship between cyclic guanosine monophosphate accumulation and relaxation of canine trachealis induced by nitrovasodilators.
Zhou HL; Torphy TJ
J Pharmacol Exp Ther; 1991 Sep; 258(3):972-8. PubMed ID: 1679854
[TBL] [Abstract][Full Text] [Related]
17. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
[TBL] [Abstract][Full Text] [Related]
18. Reversal of nitroglycerin tolerance in vitro by the cGMP-phosphodiesterase inhibitor zaprinast.
Pagani ED; VanAller GS; O'Connor B; Silver PJ
Eur J Pharmacol; 1993 Oct; 243(2):141-7. PubMed ID: 8276063
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory action of melatonin on the contractile response to 5-hydroxytryptamine in various isolated vascular smooth muscles.
Satake N; Shibata S; Takagi T
Gen Pharmacol; 1986; 17(5):553-8. PubMed ID: 3781206
[TBL] [Abstract][Full Text] [Related]
20. Potentiating effect of nicorandil, an antianginal agent, on relaxation induced by isoproterenol in isolated rat aorta: involvement of cyclic GMP-inhibitable cyclic AMP phosphodiesterase.
Satake N; Zhou Q; Morikawa M; Inoue M; Shibata S
J Cardiovasc Pharmacol; 1995 Mar; 25(3):489-94. PubMed ID: 7769818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
